The global Targeted Drug Delivery Device market size was valued at US$ million in 2023. With growing demand in downstream market, the Targeted Drug Delivery Device is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period.
The research report highlights the growth potential of the global Targeted Drug Delivery Device market. Targeted Drug Delivery Device are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Targeted Drug Delivery Device. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Targeted Drug Delivery Device market.
Targeted Drug Delivery Device is a method of delivery medication in some parts of the body. This means of delivery is largely founded on nanomedicine, which plans to employ nanoparticle-mediated drug delivery in order to combat the downfalls of conventional drug delivery. These nanoparticles would be loaded with drugs and targeted to specific parts where there is solely diseased tissue, thereby avoiding interaction with healthy tissue. The goal of the Targeted Drug Delivery is to prolong, localize, target and have a protected drug interaction with the diseased tissue. The conventional drug delivery system is the absorption of the drug across a biological membrane, whereas the targeted release system releases the drug in a dosage form. The advantages to the targeted release system is the reduction in the frequency of the dosages taken by the patient, having a more uniform effect of the drug, reduction of drug side-effects, and reduced fluctuation in circulating drug levels. The disadvantage of the system is high cost, which makes productivity more difficult and the reduced ability to adjust the dosages. (Wikipedia)
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Key Features:
The report on Targeted Drug Delivery Device market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Targeted Drug Delivery Device market. It may include historical data, market segmentation by Type (e.g., Eye, Brain), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Targeted Drug Delivery Device market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Targeted Drug Delivery Device market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Targeted Drug Delivery Device industry. This include advancements in Targeted Drug Delivery Device technology, Targeted Drug Delivery Device new entrants, Targeted Drug Delivery Device new investment, and other innovations that are shaping the future of Targeted Drug Delivery Device.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Targeted Drug Delivery Device market. It includes factors influencing customer ' purchasing decisions, preferences for Targeted Drug Delivery Device product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Targeted Drug Delivery Device market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Targeted Drug Delivery Device market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Targeted Drug Delivery Device market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Targeted Drug Delivery Device industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Targeted Drug Delivery Device market.
Market Segmentation:
Targeted Drug Delivery Device market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
by Target Organ
Eye
Brain
Heart
Breast
Abdomen
Others
by Type of Biologic Delivered
Cell
Protein
Enzyme
Plasmid
Antibody
Small Peptide
Modified RNA
Growth Factor
Neurotransmitter
by Therapy Delivered
Cell Therapy
RNA Therapy
Gene Therapy
Immunotherapy
Stem Cell Therapy
Segmentation by application
Metabolic Disorder
Ophthalmic Disease
Oncological Disorder
Neurological Disorder
Cardiovascular Disorder
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
4D Molecular Therapeutics
AbbVie
Abeona Therapeutics
Advaxis
Alcyone Lifesciences
AlphaVax
Amgen
Amicus Therapeutics
Anaeropharma Science
AnGes
AskBio
Astellas Pharma
AstraZeneca
Athersys
BioCardia
Biogen
BioInvent
BioRestorative Therapies
bluebird bio
Boston Scientific
CellProthera
Celsion
Celyad
Evonik
Kadimastem
Medtronic
Novartis
Sanofi
SOTIO
Takeda
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Targeted Drug Delivery Device Market Size 2019-2030
2.1.2 Targeted Drug Delivery Device Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Targeted Drug Delivery Device Segment by Type
2.2.1 Eye
2.2.2 Brain
2.2.3 Heart
2.2.4 Breast
2.2.5 Abdomen
2.2.6 Others
2.3 Targeted Drug Delivery Device Market Size by Type
2.3.1 Targeted Drug Delivery Device Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Targeted Drug Delivery Device Market Size Market Share by Type (2019-2024)
2.4 Targeted Drug Delivery Device Segment by Application
2.4.1 Metabolic Disorder
2.4.2 Ophthalmic Disease
2.4.3 Oncological Disorder
2.4.4 Neurological Disorder
2.4.5 Cardiovascular Disorder
2.4.6 Others
2.5 Targeted Drug Delivery Device Market Size by Application
2.5.1 Targeted Drug Delivery Device Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Targeted Drug Delivery Device Market Size Market Share by Application (2019-2024)
3 Targeted Drug Delivery Device Market Size by Player
3.1 Targeted Drug Delivery Device Market Size Market Share by Players
3.1.1 Global Targeted Drug Delivery Device Revenue by Players (2019-2024)
3.1.2 Global Targeted Drug Delivery Device Revenue Market Share by Players (2019-2024)
3.2 Global Targeted Drug Delivery Device Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Targeted Drug Delivery Device by Regions
4.1 Targeted Drug Delivery Device Market Size by Regions (2019-2024)
4.2 Americas Targeted Drug Delivery Device Market Size Growth (2019-2024)
4.3 APAC Targeted Drug Delivery Device Market Size Growth (2019-2024)
4.4 Europe Targeted Drug Delivery Device Market Size Growth (2019-2024)
4.5 Middle East & Africa Targeted Drug Delivery Device Market Size Growth (2019-2024)
5 Americas
5.1 Americas Targeted Drug Delivery Device Market Size by Country (2019-2024)
5.2 Americas Targeted Drug Delivery Device Market Size by Type (2019-2024)
5.3 Americas Targeted Drug Delivery Device Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Targeted Drug Delivery Device Market Size by Region (2019-2024)
6.2 APAC Targeted Drug Delivery Device Market Size by Type (2019-2024)
6.3 APAC Targeted Drug Delivery Device Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Targeted Drug Delivery Device by Country (2019-2024)
7.2 Europe Targeted Drug Delivery Device Market Size by Type (2019-2024)
7.3 Europe Targeted Drug Delivery Device Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Targeted Drug Delivery Device by Region (2019-2024)
8.2 Middle East & Africa Targeted Drug Delivery Device Market Size by Type (2019-2024)
8.3 Middle East & Africa Targeted Drug Delivery Device Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Targeted Drug Delivery Device Market Forecast
10.1 Global Targeted Drug Delivery Device Forecast by Regions (2025-2030)
10.1.1 Global Targeted Drug Delivery Device Forecast by Regions (2025-2030)
10.1.2 Americas Targeted Drug Delivery Device Forecast
10.1.3 APAC Targeted Drug Delivery Device Forecast
10.1.4 Europe Targeted Drug Delivery Device Forecast
10.1.5 Middle East & Africa Targeted Drug Delivery Device Forecast
10.2 Americas Targeted Drug Delivery Device Forecast by Country (2025-2030)
10.2.1 United States Targeted Drug Delivery Device Market Forecast
10.2.2 Canada Targeted Drug Delivery Device Market Forecast
10.2.3 Mexico Targeted Drug Delivery Device Market Forecast
10.2.4 Brazil Targeted Drug Delivery Device Market Forecast
10.3 APAC Targeted Drug Delivery Device Forecast by Region (2025-2030)
10.3.1 China Targeted Drug Delivery Device Market Forecast
10.3.2 Japan Targeted Drug Delivery Device Market Forecast
10.3.3 Korea Targeted Drug Delivery Device Market Forecast
10.3.4 Southeast Asia Targeted Drug Delivery Device Market Forecast
10.3.5 India Targeted Drug Delivery Device Market Forecast
10.3.6 Australia Targeted Drug Delivery Device Market Forecast
10.4 Europe Targeted Drug Delivery Device Forecast by Country (2025-2030)
10.4.1 Germany Targeted Drug Delivery Device Market Forecast
10.4.2 France Targeted Drug Delivery Device Market Forecast
10.4.3 UK Targeted Drug Delivery Device Market Forecast
10.4.4 Italy Targeted Drug Delivery Device Market Forecast
10.4.5 Russia Targeted Drug Delivery Device Market Forecast
10.5 Middle East & Africa Targeted Drug Delivery Device Forecast by Region (2025-2030)
10.5.1 Egypt Targeted Drug Delivery Device Market Forecast
10.5.2 South Africa Targeted Drug Delivery Device Market Forecast
10.5.3 Israel Targeted Drug Delivery Device Market Forecast
10.5.4 Turkey Targeted Drug Delivery Device Market Forecast
10.5.5 GCC Countries Targeted Drug Delivery Device Market Forecast
10.6 Global Targeted Drug Delivery Device Forecast by Type (2025-2030)
10.7 Global Targeted Drug Delivery Device Forecast by Application (2025-2030)
11 Key Players Analysis
11.1 4D Molecular Therapeutics
11.1.1 4D Molecular Therapeutics Company Information
11.1.2 4D Molecular Therapeutics Targeted Drug Delivery Device Product Offered
11.1.3 4D Molecular Therapeutics Targeted Drug Delivery Device Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 4D Molecular Therapeutics Main Business Overview
11.1.5 4D Molecular Therapeutics Latest Developments
11.2 AbbVie
11.2.1 AbbVie Company Information
11.2.2 AbbVie Targeted Drug Delivery Device Product Offered
11.2.3 AbbVie Targeted Drug Delivery Device Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 AbbVie Main Business Overview
11.2.5 AbbVie Latest Developments
11.3 Abeona Therapeutics
11.3.1 Abeona Therapeutics Company Information
11.3.2 Abeona Therapeutics Targeted Drug Delivery Device Product Offered
11.3.3 Abeona Therapeutics Targeted Drug Delivery Device Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Abeona Therapeutics Main Business Overview
11.3.5 Abeona Therapeutics Latest Developments
11.4 Advaxis
11.4.1 Advaxis Company Information
11.4.2 Advaxis Targeted Drug Delivery Device Product Offered
11.4.3 Advaxis Targeted Drug Delivery Device Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Advaxis Main Business Overview
11.4.5 Advaxis Latest Developments
11.5 Alcyone Lifesciences
11.5.1 Alcyone Lifesciences Company Information
11.5.2 Alcyone Lifesciences Targeted Drug Delivery Device Product Offered
11.5.3 Alcyone Lifesciences Targeted Drug Delivery Device Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Alcyone Lifesciences Main Business Overview
11.5.5 Alcyone Lifesciences Latest Developments
11.6 AlphaVax
11.6.1 AlphaVax Company Information
11.6.2 AlphaVax Targeted Drug Delivery Device Product Offered
11.6.3 AlphaVax Targeted Drug Delivery Device Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 AlphaVax Main Business Overview
11.6.5 AlphaVax Latest Developments
11.7 Amgen
11.7.1 Amgen Company Information
11.7.2 Amgen Targeted Drug Delivery Device Product Offered
11.7.3 Amgen Targeted Drug Delivery Device Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Amgen Main Business Overview
11.7.5 Amgen Latest Developments
11.8 Amicus Therapeutics
11.8.1 Amicus Therapeutics Company Information
11.8.2 Amicus Therapeutics Targeted Drug Delivery Device Product Offered
11.8.3 Amicus Therapeutics Targeted Drug Delivery Device Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Amicus Therapeutics Main Business Overview
11.8.5 Amicus Therapeutics Latest Developments
11.9 Anaeropharma Science
11.9.1 Anaeropharma Science Company Information
11.9.2 Anaeropharma Science Targeted Drug Delivery Device Product Offered
11.9.3 Anaeropharma Science Targeted Drug Delivery Device Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Anaeropharma Science Main Business Overview
11.9.5 Anaeropharma Science Latest Developments
11.10 AnGes
11.10.1 AnGes Company Information
11.10.2 AnGes Targeted Drug Delivery Device Product Offered
11.10.3 AnGes Targeted Drug Delivery Device Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 AnGes Main Business Overview
11.10.5 AnGes Latest Developments
11.11 AskBio
11.11.1 AskBio Company Information
11.11.2 AskBio Targeted Drug Delivery Device Product Offered
11.11.3 AskBio Targeted Drug Delivery Device Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 AskBio Main Business Overview
11.11.5 AskBio Latest Developments
11.12 Astellas Pharma
11.12.1 Astellas Pharma Company Information
11.12.2 Astellas Pharma Targeted Drug Delivery Device Product Offered
11.12.3 Astellas Pharma Targeted Drug Delivery Device Revenue, Gross Margin and Market Share (2019-2024)
11.12.4 Astellas Pharma Main Business Overview
11.12.5 Astellas Pharma Latest Developments
11.13 AstraZeneca
11.13.1 AstraZeneca Company Information
11.13.2 AstraZeneca Targeted Drug Delivery Device Product Offered
11.13.3 AstraZeneca Targeted Drug Delivery Device Revenue, Gross Margin and Market Share (2019-2024)
11.13.4 AstraZeneca Main Business Overview
11.13.5 AstraZeneca Latest Developments
11.14 Athersys
11.14.1 Athersys Company Information
11.14.2 Athersys Targeted Drug Delivery Device Product Offered
11.14.3 Athersys Targeted Drug Delivery Device Revenue, Gross Margin and Market Share (2019-2024)
11.14.4 Athersys Main Business Overview
11.14.5 Athersys Latest Developments
11.15 BioCardia
11.15.1 BioCardia Company Information
11.15.2 BioCardia Targeted Drug Delivery Device Product Offered
11.15.3 BioCardia Targeted Drug Delivery Device Revenue, Gross Margin and Market Share (2019-2024)
11.15.4 BioCardia Main Business Overview
11.15.5 BioCardia Latest Developments
11.16 Biogen
11.16.1 Biogen Company Information
11.16.2 Biogen Targeted Drug Delivery Device Product Offered
11.16.3 Biogen Targeted Drug Delivery Device Revenue, Gross Margin and Market Share (2019-2024)
11.16.4 Biogen Main Business Overview
11.16.5 Biogen Latest Developments
11.17 BioInvent
11.17.1 BioInvent Company Information
11.17.2 BioInvent Targeted Drug Delivery Device Product Offered
11.17.3 BioInvent Targeted Drug Delivery Device Revenue, Gross Margin and Market Share (2019-2024)
11.17.4 BioInvent Main Business Overview
11.17.5 BioInvent Latest Developments
11.18 BioRestorative Therapies
11.18.1 BioRestorative Therapies Company Information
11.18.2 BioRestorative Therapies Targeted Drug Delivery Device Product Offered
11.18.3 BioRestorative Therapies Targeted Drug Delivery Device Revenue, Gross Margin and Market Share (2019-2024)
11.18.4 BioRestorative Therapies Main Business Overview
11.18.5 BioRestorative Therapies Latest Developments
11.19 bluebird bio
11.19.1 bluebird bio Company Information
11.19.2 bluebird bio Targeted Drug Delivery Device Product Offered
11.19.3 bluebird bio Targeted Drug Delivery Device Revenue, Gross Margin and Market Share (2019-2024)
11.19.4 bluebird bio Main Business Overview
11.19.5 bluebird bio Latest Developments
11.20 Boston Scientific
11.20.1 Boston Scientific Company Information
11.20.2 Boston Scientific Targeted Drug Delivery Device Product Offered
11.20.3 Boston Scientific Targeted Drug Delivery Device Revenue, Gross Margin and Market Share (2019-2024)
11.20.4 Boston Scientific Main Business Overview
11.20.5 Boston Scientific Latest Developments
11.21 CellProthera
11.21.1 CellProthera Company Information
11.21.2 CellProthera Targeted Drug Delivery Device Product Offered
11.21.3 CellProthera Targeted Drug Delivery Device Revenue, Gross Margin and Market Share (2019-2024)
11.21.4 CellProthera Main Business Overview
11.21.5 CellProthera Latest Developments
11.22 Celsion
11.22.1 Celsion Company Information
11.22.2 Celsion Targeted Drug Delivery Device Product Offered
11.22.3 Celsion Targeted Drug Delivery Device Revenue, Gross Margin and Market Share (2019-2024)
11.22.4 Celsion Main Business Overview
11.22.5 Celsion Latest Developments
11.23 Celyad
11.23.1 Celyad Company Information
11.23.2 Celyad Targeted Drug Delivery Device Product Offered
11.23.3 Celyad Targeted Drug Delivery Device Revenue, Gross Margin and Market Share (2019-2024)
11.23.4 Celyad Main Business Overview
11.23.5 Celyad Latest Developments
11.24 Evonik
11.24.1 Evonik Company Information
11.24.2 Evonik Targeted Drug Delivery Device Product Offered
11.24.3 Evonik Targeted Drug Delivery Device Revenue, Gross Margin and Market Share (2019-2024)
11.24.4 Evonik Main Business Overview
11.24.5 Evonik Latest Developments
11.25 Kadimastem
11.25.1 Kadimastem Company Information
11.25.2 Kadimastem Targeted Drug Delivery Device Product Offered
11.25.3 Kadimastem Targeted Drug Delivery Device Revenue, Gross Margin and Market Share (2019-2024)
11.25.4 Kadimastem Main Business Overview
11.25.5 Kadimastem Latest Developments
11.26 Medtronic
11.26.1 Medtronic Company Information
11.26.2 Medtronic Targeted Drug Delivery Device Product Offered
11.26.3 Medtronic Targeted Drug Delivery Device Revenue, Gross Margin and Market Share (2019-2024)
11.26.4 Medtronic Main Business Overview
11.26.5 Medtronic Latest Developments
11.27 Novartis
11.27.1 Novartis Company Information
11.27.2 Novartis Targeted Drug Delivery Device Product Offered
11.27.3 Novartis Targeted Drug Delivery Device Revenue, Gross Margin and Market Share (2019-2024)
11.27.4 Novartis Main Business Overview
11.27.5 Novartis Latest Developments
11.28 Sanofi
11.28.1 Sanofi Company Information
11.28.2 Sanofi Targeted Drug Delivery Device Product Offered
11.28.3 Sanofi Targeted Drug Delivery Device Revenue, Gross Margin and Market Share (2019-2024)
11.28.4 Sanofi Main Business Overview
11.28.5 Sanofi Latest Developments
11.29 SOTIO
11.29.1 SOTIO Company Information
11.29.2 SOTIO Targeted Drug Delivery Device Product Offered
11.29.3 SOTIO Targeted Drug Delivery Device Revenue, Gross Margin and Market Share (2019-2024)
11.29.4 SOTIO Main Business Overview
11.29.5 SOTIO Latest Developments
11.30 Takeda
11.30.1 Takeda Company Information
11.30.2 Takeda Targeted Drug Delivery Device Product Offered
11.30.3 Takeda Targeted Drug Delivery Device Revenue, Gross Margin and Market Share (2019-2024)
11.30.4 Takeda Main Business Overview
11.30.5 Takeda Latest Developments
12 Research Findings and Conclusion
听
听
*If Applicable.
